EON: Enhanced Online News (press release) Among the products launched under Dr. Dixon's leadership were ABILIFY® ( aripiprazole ) and REYATAZ® (atazanavir sulfate), both of which were ranked in the top ten of recent pharmaceutical product launches. Dr. Dixon also oversaw the Market Research, ...
CNW Telbec (Communiqué de presse) MONTRÉAL, le 6 juin 2013 /CNW/ - Abilify® ( aripiprazole ) a reçu une nouvelle approbation de Santé Canada et peut être administré comm...
Seeking Alpha ... concentrations in the therapeutic range were obtained on the first day of dosing, avoiding the need to take oral antipsychotics during the first days post-injection, a considerable simplification compared to some competitive LAIs such as Risperidal ...
CNW Telbec (Communiqué de presse) MONTRÉAL, le 6 juin 2013 /CNW/ - Abilify® ( aripiprazole ) a reçu une nouvelle approbation de Santé Canada et peut être administré comme traitement adjuvant, ou traitement d'appoint, aux antidépresseurs dans le traitement du trouble dépressif majeur ... and more »
CNW Telbec (Communiqué de presse) MONTRÉAL, le 6 juin 2013 /CNW/ - Abilify® ( aripiprazole ) a reçu une nouvelle approbation de Santé Canada et peut être administré comme traitement adjuvant, ou traitement d'appoint, aux antidépresseurs dans le traitement du trouble dépressif majeur ...
Victoria Times Colonist Only aripiprazole , or Abilify, is approved for use in teens 15-17 — and only for schizophrenia. “All other prescribing is off label,” Panagiotopoulos said. As of 2010-11, B.C. general practitioners were prescribing antipsychotics most often for ...
Pharmacy Times Indication: The FDA has approved Abilify Maintena ( aripiprazole ), an atypical antipsy- chotic indicated for the treatment of schizo- phrenia. Abilify Maintena is available as a lyophilized powder for reconstitution as an extended-release injectable ...
PR Newswire (press release) MONTREAL, June 6, 2013 /CNW/ - Abilify® ( aripiprazole ) has received an additional approval from Health Canada as an adjunct, or add-on, treatment to antidepressants for the treatment of major depressive disorder (MDD) in adults who had an inadequate ... and more »
CNW Telbec (Communiqué de presse) MONTRÉAL, le 6 juin 2013 /CNW/ - Abilify® ( aripiprazole ) a reçu une nouvelle approbation de Santé Canada et peut être administré comme traitement adjuvant, ou traitement d'appoint, aux antidépresseurs dans le traitement du trouble dépressif majeur ...
